Servier Overview
- Year Founded
-
1954
- Status
-
Private
- Employees
-
20,000
Servier General Information
Description
Operator of a pharmaceutical company intended to play a vital role in advancing medical science, improving patient outcomes, and addressing global healthcare challenges. The company researches, develops, and produces drugs for oncology, cardiology, metabolic, central nervous system, psychiatric, bone, muscle, and joint diseases, enabling doctors to prescribe generic drugs with minimal side effects for low-cost treatments.
Contact Information
Website
www.servier.comCorporate Office
- 50 Rue Carnot
- 92284 Suresnes
- France
Corporate Office
- 50 Rue Carnot
- 92284 Suresnes
- France
Servier Comparisons
Industry
Financing
Details
Servier Competitors (37)
One of Servier’s 37 competitors is Chiesi Farmaceutici, a Private Debt Financed company based in Parma, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Servier Patents
Servier Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026229590-A1 | Polycyclic derivatives, pharmaceutical compositions containing them, their combination with one or more anti-cancer agents, and their uses as pro-apoptotic agents | Pending | 30-Apr-2025 | ||
| WO-2026220079-A1 | Combination of ivosidenib, venetoclax and azacitidine for use in the treatment of aml or mds/aml | Pending | 18-Apr-2025 | ||
| WO-2026219847-A1 | Antibodies to il21r and compositions thereof | Pending | 14-Apr-2025 | ||
| WO-2026082692-A1 | Antibodies to cd40 and compositions thereof | Pending | 15-Oct-2024 | ||
| WO-2026068485-A1 | New process for the synthesis of 2',4'-bna ncnucleoside analogues | Pending | 25-Sep-2024 | C07H1/00 |
Servier Signals
Servier Investments & Acquisitions (21)
Servier’s most recent deal was a Merger/Acquisition with Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) for . The deal was made on 01-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) | 01-Jun-2026 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Cytospire | 05-May-2026 | Early Stage VC | Biotechnology | ||
| Day One Biopharmaceuticals | 23-Apr-2026 | Merger/Acquisition | Drug Discovery | ||
| Kaerus Bioscience (KER-0193 Drug in London, United Kingdom) | 08-Sep-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) | 23-May-2025 | Corporate Asset Purchase | Buildings and Property |
Servier Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Day One Biopharmaceuticals | Brisbane, CA | 2018 | |
| Symphogen | Ballerup, Denmark | 2000 | |
| Arts Et Technique Du Progres | Orleans, France | 1982 | |
| Servier Laboratories Pension Fund | Bells hill, United Kingdom | 1963 | |
| Egis Pharmaceuticals | Budapest, Hungary | 1913 |
Servier FAQs
-
When was Servier founded?
Servier was founded in 1954.
-
Where is Servier headquartered?
Servier is headquartered in Suresnes, France.
-
What is the size of Servier?
Servier has 20,000 total employees.
-
What industry is Servier in?
Servier’s primary industry is Drug Discovery.
-
Is Servier a private or public company?
Servier is a Private company.
-
What is Servier’s current revenue?
The current revenue for Servier is .
-
Who are Servier’s competitors?
Chiesi Farmaceutici, The Zambon Group, Merck & Co., Pfizer Pakistan, and Genentech are some of the 37 competitors of Servier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process